Iain W. Duncan

Horizon Therapeutics is a late stage biopharmaceutical company focused on the development of prescription drugs for mild to moderate pain relief. It is creating novel therapies through innovative combinations of existing pharmaceutical products. The Company is building a portfolio of proprietary formulations that seek to improve safety, efficacy, and patient compliance.

Corus Pharma, Inc. develops drugs to treat needs in infectious diseases and respiratory areas. The firm's core competencies reside in the identification of drugs, rapid clinical development, and FDA approval of its products. The firm was founded in January 2001 by A. Bruce Montgomery and is headquartered in Seattle, WA.

Lyondell Chemical Co. manufactures and distributes chemicals & plastics, produces fuel products, and refines heavy & high-sulfur crude oil. The company operates in four segments: Ethylene Co-Products and Derivatives, Propylene Oxide & Related Products, Refining, and Inorganic Chemicals. The company's products are used in the clothing, food packaging, household furnishings, automotive parts, construction, home-building materials, paints, and coating industries. The company was founded in 1985 and is headquartered in Houston, TX.

Part of Novartis AG, PathoGenesis Corp is a company that develops and markets innovative treatments for chronic infectious diseases. The company is based in Seattle, WA. The company was founded by Isaac Blech. PathoGenesis was acquired by Chiron Corp. on September 19, 2000 for $639.75 million.